$33.41
2.90%
NYSE, Jan 02, 10:19 pm CET

Hims & Hers Health Inc. Stock price

$33.41
-2.90 7.99% 1M
-14.05 29.60% 6M
+0.94 2.90% YTD
+8.21 32.58% 1Y
+27.00 421.22% 3Y
+17.73 113.07% 5Y
+23.61 240.92% 10Y
+23.61 240.92% 20Y
NYSE, Closing price Fri, Jan 02 2026
+0.94 2.90%

New AI Insights on Hims & Hers Health Inc. Insights AI Insights on Hims & Hers Health Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$7.6b
Enterprise Value
$7.9b
Net debt
$341.3m
Cash
$629.7m
Shares outstanding
227.5m
Valuation (TTM | estimate)
P/E
61.9 | 70.8
P/S
3.4 | 3.2
EV/Sales
3.6 | 3.3
EV/FCF
66.5
P/B
13.1
Financial Health
Equity Ratio
67.4%
Return on Equity
26.4%
ROCE
7.4%
ROIC
11.2%
Debt/Equity
1.7
Financials (TTM | estimate)
Revenue
$2.2b | $2.4b
EBITDA
$174.3m | $319.7m
EBIT
$131.8m | $116.4m
Net Income
$133.8m | $107.4m
Free Cash Flow
$119.5m
Growth (TTM | estimate)
Revenue
78.0% | 62.3%
EBITDA
195.2% | 275.7%
EBIT
190.6% | 71.2%
Net Income
32.1% | -14.8%
Free Cash Flow
-20.1%
Margin (TTM | estimate)
Gross
75.0%
EBITDA
7.9% | 13.3%
EBIT
6.0%
Net
6.1% | 4.5%
Free Cash Flow
5.4%
More
EPS
$0.5
FCF per Share
$0.5
Short interest
35.2%
Employees
2k
Rev per Employee
$900.0k
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Hims & Hers Health Inc. forecast:

8x Buy
38%
11x Hold
52%
2x Sell
10%

Analyst Opinions

21 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
38%
Hold
52%
Sell
10%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,211 2,211
78% 78%
100%
- Direct Costs 552 552
136% 136%
25%
1,658 1,658
65% 65%
75%
- Selling and Administrative Expenses 1,527 1,527
59% 59%
69%
- Research and Development Expense - -
-
-
174 174
195% 195%
8%
- Depreciation and Amortization 42 42
210% 210%
2%
EBIT (Operating Income) EBIT 132 132
191% 191%
6%
Net Profit 134 134
32% 32%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Negative
Forbes
one day ago
Hims & Hers Health (HIMS) stock has experienced a 7-day losing streak, resulting in total losses of 8.7% over this time frame. The company's market capitalization has plummeted by approximately $699 million in the past week, currently sitting at $7.3 billion.
Neutral
24/7 Wall Street
5 days ago
Hims & Hers Health (NYSE: HIMS) went public in January 2021 through a SPAC merger, positioning itself as a multi-specialty telehealth platform offering prescription medications, mental health support, and personal care products.
Positive
Seeking Alpha
15 days ago
My 2025 picks outperformed the S&P 500 by 9.4% and Nasdaq 100 by 5.9%, validating my growth-value approach. Each stock on this list is operating in a different market segment and two are based in Europe, offering geographic diversification. The featured stocks all show significant undervaluation potential based on rather conservative growth scenarios.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,637
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today